Jan 132017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– CANADA, Vancouver – InMed Pharmaceuticals, Inc. (CSE: IN / OTCQB: IMLFF), today announced that Martin Bott, VP of Corporate Finance and Investment Banking at Eli Lilly & Company, has been appointed to InMed Board of Directors effective immediately.… => Read more

InMed Pharmaceuticals appoints Martin Bott to its Board of Directors

From:: InMed Pharmaceuticals appoints Martin Bott to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: